Search

AF solution

Chevron
Cardiac Organoid_main
Normal Organoid

Cardiac Organoid

Cardiac Organoid_main

  • Cardiac Organoids: Lifelike Functionality
▶ Experience the rhythmic pulseof our cardiac organoids, mimicking real human heart functionality for groundbreaking research.
  • Simplified Cultivation: Enhanced Efficiency
▶ Our cultivation process eliminates extracellular matrices, reducing variabilityand maximizing the efficiencyof functional cardiac organoid production.
  • Advanced Differentiation: Superior Maturation
▶ We've refined our differentiation methods to better replicate the human heart, achieving a precise balanceof myocardialand non-myocardial cells for more mature organoid functions.

Organism
Product Type
Organoid
Tissue
iPSC
Disease

Applications

Efficacy assay

Organoids are three-dimensional mini organs that mimic the functions of respective organs, reproducing their complex physiological structures and functions. Verify their efficacy with our advanced technology.

Toxicity test

Organoids are three-dimensional mini organs that mimic the functions of respective organs, reproducing their complex physiological structures and functions. Assess their toxicity with our advanced technology!

Table of Contents

Innovate Cardiac Solutions with iPSC-Derived Organoids

Leverage our breakthrough cardiac organoids, engineered from human-induced pluripotent stem cells (iPSCs).
By transforming 3D embryoid bodies through precise signal manipulation, we create organoids that emulate heart tissue, advancing personalized cardiac research and therapy.

Generation of cardiac organoids

To create cardiac organoids, we utilized Wnt signaling activators and inhibitors, which are crucial for heart development, at various stages of differentiation within embryoid bodies.
By day eight of differentiation, we observed spontaneous beating in the organoids.

Characterization of cardiac organoid model

The cardiac organoids produced are composed similarly to the human heart, containing cardiomyocytes and non-muscle cells like cardiac fibroblasts and endothelial cells.
Through FACS analysis, it was determined that cardiomyocytes constitute about 65% of the cell population, with the majority of the non-muscle cells being fibroblasts and endothelial cells.

Using immunofluorescence, we have confirmed the expression of myocardial markers (cTnT, α-actinin), fibroblast markers (α-SMA), and endothelial cell markers (CD31) in our cardiac organoids.
This method allows for detailed visualization and verification of specific cellular components critical to heart tissue function.

Patch clamp analysis

Real-time recording of action potentials

To analyze the electro physiological properties of cardiac organoids with spontaneous beating, we employ the patch clamp technique. By inserting electrodes into the cell membranes of the cardiac organoids, we can monitor action potentials in real-time, providing valuable insights into their functional behavior.

Cardiac organoids have electrophysiological properties similiar to cardiac tissue

Connect with Us

By submitting your details, you confirm that you have reviewed and agree with the Lambda Biologics Privacy Policy.